Insider Cluster (2 insiders) ·Filed Jul 23, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 3/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $319K total
Actionable Insight • Neutral

The CEO's $3.4M sale is routine in size relative to UTHR's $22.4B market cap and does not signal a bearish view. Monitor for any upcoming earnings or pipeline catalysts that could explain the timing, but this cluster alone does not warrant a trading action.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
UTHR ▼ -2.08% at T+20d
NEUTRAL call ✗ call lost -2.08% · α vs SPY -5.39% · entry $529.53 → $518.50
Next anchor: T+60d in 13d
Latest observation: T+47 -2.20% FF3 residual α
Entry anchored
Jul 22, 03:59 PM ET
via exchange tick
T+1d
-0.20%
call -0.20% · α -0.30%
$528.47
settled 2mo ago
T+5d
-0.70%
call -0.70% · α -1.18%
$525.82
settled 2mo ago
T+20d
-2.08%
call -2.08% · α -5.39%
$518.50
settled 6w ago
T+60d
—
call — · α —
—
in 13d

Price Chart

Loading chart...

Executive Summary

CEO Martine Rothblatt sold $3.4M worth of UTHR shares across 9 open-market trades on July 22, 2026, at prices ranging from $526.84 to $539.47. EVP Paul Mahon also sold $64K on July 16. The CEO's $3.4M sale represents ~0.015% of UTHR's $22.4B market cap, which is trivial in proportion. The cluster is overwhelmingly sell-side but immaterial relative to company size, and the CEO's trades may be routine diversification or tax planning. Non-cash director grants (22,030 shares total at $0) are neutral. No 10b5-1 pattern is evident from the data, but the dollar amount is too small to signal a material bearish view.

Key Financial Metrics

Direction
selling
Total Value
$3.5M
Insiders
2

Key Facts

  • CEO Martine Rothblatt sold 6,494 shares total across 9 open-market trades on July 22, 2026, for ~$3.4M
  • EVP Paul Mahon sold 120 shares on July 16, 2026, for ~$64K
  • Total insider sales of ~$3.5M represent ~0.016% of UTHR's $22.4B market cap
  • 8 directors received non-cash stock grants totaling 22,030 shares at $0 on July 22, 2026
  • No insider open-market purchases in the cluster

Financial Impact

Total insider sales of ~$3.5M, or ~0.016% of market cap — immaterial

insider ownership

Risk Factors

  • CEO selling a large absolute dollar amount ($3.4M) could be misinterpreted as bearish by the market
  • No insider buying to offset the selling pattern

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1784880100865
91 reports for UTHR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +5.53%Feb 25, 2026
Filters
Rows
Reports for UTHR — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$500.35 $497.31▼ −0.61%▼ −2.72%$573.51 (+14.62%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$497.11 $494.63▼ −0.50%▼ −0.28%$573.51 (+15.37%)
Sep 10, 2026
22d ago
Insider Cluster
MIXED ★ 4/10
$503.86 $497.27▼ −1.31%▼ −0.81%$573.51 (+13.82%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$506.82 $498.48▼ −1.65%▼ −0.99%$573.51 (+13.16%)
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$487.61 $502.70▲ +3.09%▲ +4.30%$573.51 (+17.62%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$488.16 $497.11▲ +1.83%▲ +2.98%$573.51 (+17.48%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$515.46 $487.61▼ −5.40%▼ −5.51%$573.51 (+11.26%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$527.91 $492.02▼ −6.80%▼ −6.03%$573.51 (+8.64%)
Aug 26, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$516.68 $492.02▼ −4.77%▼ −4.65%$573.51 (+11.00%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$516.68 $492.02▼ −4.77%▼ −4.65%$573.51 (+11.00%)
Showing 10 of 91

US Market Status

Market Open — Closes in 6h 24m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 24, 2026